Health Canada open data (page 16)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Vitrakvi - Notice of Compliance with Conditions - Qualifying Notice
- Arzerra - Notice of Compliance with Conditions - Qualifying Notice
- Balversa - Notice of Compliance with Conditions - Qualifying Notice
- Blincyto - Notice of Compliance with Conditions - Qualifying Notice
- Notice: Prescription Drug List (PDL): Avilamycin
- Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)
- Notice: Prescription Drug List (PDL): Diclofenac
- Notice: Prescription Drug List (PDL): Esomeprazole
- Notice: Prescription Drug List (PDL): Omeprazole
- Notice: Prescription Drug List (PDL): Fluticasone propionate
- Notice: Prescription Drug List (PDL): Human and Veterinary Antimicrobials
- Notice: Prescription Drug List (PDL): Hydrocortisone
- Notice: Prescription Drug List (PDL): Hyoscine butylbromide
- Notice: Prescription Drug List (PDL): Minoxidil
- Notice: Prescription Drug List (PDL): Naloxone
- Notice: Prescription Drug List (PDL): Naproxen
- Notice: Prescription Drug List (PDL): Nicotine Qualifier Clarification
- Notice: Prescription Drug List (PDL): Polymyxin B
- Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)
- Notice: Prescription Drug List (PDL): Triamcinolone acetonide
- Notice: Prescription Drug List (PDL): Vitamin D
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)
- Notice: Prescription Drug List (PDL): Multiple Additions (2021-11-15)
- Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)
- Notice: Prescription Drug List (PDL): Multiple additions (2020-07-15)
- Guidance Document : Post-Notice of Compliance (NOC) Changes: Quality Document
- Guidance Document: Notice of Compliance with Conditions (NOC/c)
- Guidance Document: Patented Medicines (Notice of Compliance) Regulations
- Imbruvica - Notice of Compliance with Conditions - Qualifying Notice - 2015 - Health Canada
- Keytruda - Notice of Compliance with Conditions - Qualifying Notice
- Libtayo - Notice of Compliance with Conditions - Qualifying Notice
- Lynparza - Notice of Compliance with Conditions - Qualifying Notice
- Ocrevus – Notice of Compliance with Conditions - Qualifying Notice
- Imfinzi – Notice of Compliance with Conditions - Qualifying Notice
- Prochymal: Notice of Compliance with Conditions - Qualifying Notice
- Notice - Prescription Drug List (PDL): Esomeprazole
- Notice - Prescription Drug List (PDL): Hydrocortisone
- Notice - Prescription Drug List (PDL): Hydroquinone
- Notice - Prescription Drug List (PDL): Ibuprofen
- Notice - Prescription Drug List (PDL): Levonorgestrel
- Notice - Prescription Drug List (PDL): Lovastatin
- Notice - Prescription Drug List (PDL): Mometasone furoate
- Notice - Prescription Drug List (PDL): Polymyxin B
- Notice - Prescription Drug List (PDL): Triamcinolone acetonide
- Notice of Compliance - Drug Products
- List of Influenza Vaccines for Which Supplements to New Drug Submissions Can Be Filed
- Notice - Draft Guidance Document: Administrative Processing of Drug Submissions and Applications Involving Human or Disinfectant Drugs